Analyst Ratings for Valeant Pharmaceuticals International Inc. (VRX)Updated: 2017-07-26
An average rating of Hold has been given to Valeant Pharmaceuticals International Inc. (NYSE:VRX) by analysts covering the stock. A consensus rating of Hold was previously issued for VRX last month.
A buy rating was issued by 3 analysts, 1 gave an overweight rating, 13 gave a hold rating, 1 gave an underweight rating, and 4 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. During this time, the number of analysts bearish on the stock has increased by 0.
Investment analysts gave a few price targets for VRX. The maximum price target given was 35, implying potential capital gains of 95.26 percent. The most pessimistic analyst gave a price target of 8, implying a possible loss of -55.37 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0.53 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 0.54 percent. Over the past 30 days, FY earnings estimates have also changed downwards by -0.27 percent. If we look at the last 90 days instead, we find a net average change of -6.2 percent in FY estimates.
Another thing investors often look at is the level of agreement among analysts' revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. During this time, 2 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 2 analysts that revised their FY estimates downwards.
In the trailing 52-weeks, VRX hit 32.75 at the highest peak, while it's lowest trading point was 8.31. The current market price is above the trailing year's low by 115.7 percent, and 45.27 percent lower than its 52-week high. VRX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The VRX value stock report compares VRX to some of its peers using value stock charts. The stock has a market capitalization of $7.72 billion. VRX's next earnings release will be on 0000-00-00, which is days away.